Symbols

Overlooked AI stocks ready to surge

8/26/2025 01:09pm

``` The deep research logic is organized as follows: Okay, let's tackle this question about overlooked AI stocks ready to surge. The user is interested in growth stocks, especially small caps, and has a background in bio-pharmaceuticals, sensors, and space exploration. They're looking for undervalued AI companies that might take off. First, I need to check the references provided. The user mentioned a query with P/E <15 and market cap < $1B. The results from Reference 1 show four stocks: Shutterstock (SSTK), Amesite (AMST), Veritone (VERI), and Rezolve AI (RZLV). Let me go through each stock: 1. **Shutterstock (SSTK)**: P/E is 11.72, which is below 15. Market cap is ~$753M. They partnered with OpenAI for AI image synthesis. The user is into AI, so this could be relevant. However, the user's interests are more in bio-pharma and space, so maybe not the top pick unless there's a tie-in. 2. **Amesite (AMST)**: P/E is negative (-3.19), which is tricky. Market cap is $12.35M. They launched NurseMagic Enterprise Tier for healthcare, which ties into the user's interest in bio-pharmaceuticals. The healthcare AI angle could be a good fit. Plus, the stock is very small cap, which aligns with the user's preference for growth stocks with potential. 3. **Veritone (VERI)**: P/E is negative (-3.55), market cap ~$130M. They partnered with Newsmax and Guinness World Records for content monetization. Also, they have a DoD contract. The user might be interested in their AI solutions for media and public sector, but it's a stretch from their main interests. However, the partnerships could indicate growth potential. 4. **Rezolve AI (RZLV)**: P/E is negative (-5.16), market cap ~$890M. They opened an APAC HQ in Singapore with government backing. Their focus is on retail and commerce AI. The user's interest in sensors and space might not directly relate, but the expansion into Asia could be a growth catalyst. Now, considering the user's profile: they like small caps, growth, and sectors like bio-pharma, sensors, space. Amesite's healthcare AI solution seems the most aligned. Shutterstock is more media-focused, Veritone is media/public sector, Rezolve is retail. Also, the user asked about LogicMark's growth potential and LCX cryptocurrency. While not directly related, the focus on overlooked AI stocks suggests they're looking for undervalued gems. Amesite's recent launches in healthcare could be a hidden gem. Veritone's partnerships might also indicate potential, but the negative P/E is a red flag. Rezolve's expansion could be a growth driver, but the market cap is closer to $1B, which might be a bit higher than the user's preference. I should structure the answer highlighting each stock, their alignment with the user's interests, and why they might surge. Emphasize Amesite for healthcare AI, which ties into bio-pharma. Mention Shutterstock for media AI, Veritone for content monetization, and Rezolve for retail expansion. Use tables to present the data clearly, and include the visualization as per the requirements. Make sure to cite the references correctly and keep the language engaging with emojis. ``` ### 🚀 **Conclusion** **Amesite (AMST)** and **Rezolve AI (RZLV)** stand out as overlooked AI stocks with high growth potential, aligning with your interest in small-cap, high-growth opportunities. Both companies are leveraging AI to disrupt niche markets, with Amesite targeting healthcare documentation and Rezolve AI focusing on commerce solutions. Shutterstock (SSTK) and Veritone (VERI) also show promise, though their valuations and market caps may appeal less to your focus on smaller, high-potential plays. --- ### 📊 **Analysis of Overlooked AI Stocks** #### **1. Amesite (AMST)** - **Why It’s Undervalued**: - **P/E Ratio**: -3.19 (negative due to recent losses) . - **Market Cap**: $12.35M . - **Growth Catalyst**: Launched NurseMagic Enterprise Tier for healthcare providers, pricing tied to patient census to drive recurring revenue . - **Why It Could Surge**: - Targets the $330B healthcare market . - AI-driven solution reduces documentation time from 20 minutes to 20 seconds . - Recent partnerships and product launches suggest a strategic pivot to enterprise healthcare . | Metric | Value | |------------------|----------------| | Last Price | $2.70 | | Market Cap | $12.35M | | P/E Ratio | -3.19 | | Key Focus | Healthcare AI | #### **2. Rezolve AI (RZLV)** - **Why It’s Undervalued**: - **P/E Ratio**: -5.16 (negative due to losses) . - **Market Cap**: $890.19M . - **Growth Catalyst**: Opened Asia-Pacific HQ in Singapore with multi-million-dollar government backing . - **Why It Could Surge**: - Focus on AI-driven commerce solutions for retailers and brands . - Strategic partnerships with Rakuten (Japan) and Myntra (India) . - Expansion into a $30T global commerce market . | Metric | Value | |------------------|----------------| | Last Price | $3.13 | | Market Cap | $890.19M | | P/E Ratio | -5.16 | | Key Focus | Retail AI | #### **3. Shutterstock (SSTK)** - **Why It’s Undervalued**: - **P/E Ratio**: 11.72 . - **Market Cap**: $753.83M . - **Growth Catalyst**: Partnership with OpenAI for AI image synthesis using DALL-E API . - **Why It Could Surge**: - Dominates the digital content market with 150M+ users . - AI integration could unlock new revenue streams in content creation . | Metric | Value | |------------------|----------------| | Last Price | $21.25 | | Market Cap | $753.83M | | P/E Ratio | 11.72 | | Key Focus | Media AI | #### **4. Veritone (VERI)** - **Why It’s Undervalued**: - **P/E Ratio**: -3.55 (negative due to losses) . - **Market Cap**: $129.89M . - **Growth Catalyst**: Partnerships with Newsmax and Guinness World Records for content monetization . - **Why It Could Surge**: - AI-powered Digital Media Hub enhances content searchability . - Expansion into public sector solutions (e.g., crime intelligence) . | Metric | Value | |------------------|----------------| | Last Price | $2.35 | | Market Cap | $129.89M | | P/E Ratio | -3.55 | | Key Focus | Media AI | --- ### 🌟 **Final Takeaway** For **small-cap growth stocks** with AI-driven disruption potential, **Amesite (AMST)** and **Rezolve AI (RZLV)** are the top picks. Amesite’s focus on healthcare aligns with your interest in bio-pharmaceuticals, while Rezolve AI’s expansion into Asia-Pacific could tap into high-growth markets. Shutterstock and Veritone are solid alternatives if you prefer slightly larger caps with established AI partnerships. Theme is AI; P/E Ratio < 15; Market Capitalization < $1 billion |code|stock code|stock name|Last Price|Last Change|Theme|Inclusion Reason[20250825]|P/E(TTM)[20250825]|Market Cap[20250825]|market_code| |---|---|---|---|---|---|---|---|---|---| |SSTK|SSTK.N|Shutterstock|21.25|-3.100775|||11.721013|7.5382524125E8|169| |AMST|AMST.O|Amesite|2.7|0.371747|||-3.186916|1.23463251E7|186| |VERI|VERI.O|Veritone|2.35|-0.423729|||-3.54616|1.298887535E8|185| |RZLV|RZLV.O|Rezolve AI|3.13|2.287582|||-5.156144|8.9019180977E8|185|